Quick Takeaways
- Gilde Healthcare Holding B.V. filed SCHEDULE 13D for SpyGlass Pharma, Inc. Common Stock, par value $0.00001 per share.
- Disclosed ownership: 6.6%.
- Date of event: 09 Feb 2026.
Quoteable Key Fact
"Gilde Healthcare Holding B.V. disclosed 6.6% ownership in SpyGlass Pharma, Inc. Common Stock, par value $0.00001 per share on 09 Feb 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Gilde Healthcare Holding B.V. | 6.6% | 2,187,513 | 0 | 2,187,513 | /s/ Edwin de Graaf | Edwin de Graaf/Managing Director | 0001420106 |
| Gilde Healthcare VG VI Management B.V. | 6.6% | 2,187,513 | 0 | 2,187,513 | /s/ Edwin de Graaf | Edwin de Graaf/Managing Director | |
| Cooperatieve Gilde Healthcare VG VI U.A. | 6.6% | 2,187,513 | 0 | 2,187,513 | /s/ Edwin de Graaf | Edwin de Graaf/Managing Director of Gilde Healthcare VG VI Management B.V., as Manager of Cooperatieve Gilde Healthcare VG VI U.A. | |
| Manapouri B.V. | 6.6% | 2,187,513 | 0 | 2,187,513 | /s/ Edwin de Graaf | Edwin de Graaf/Managing Director | |
| Martemanshurk B.V. | 6.6% | 2,187,513 | 0 | 2,187,513 | /s/ Pieter van der Meer | Pieter van der Meer/Managing Director |